Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice-Reference-Cited by-同舟云学术

Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice

Published:2010-03-01 Issue:1 Volume:52 Page:25-32
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lang Philipp A.,Recher Mike,Honke Nadine,Scheu Stefanie,Borkens Stephanie,Gailus Nicole,Krings Caroline,Meryk Andreas,Kulawik Andreas,Cervantes-Barragan Luisa,Van Rooijen Nico,Kalinke Ulrich,Ludewig Burkhard,Hengartner Hans,Harris Nicola,Häussinger Dieter,Ohashi Pamela S.,Zinkernagel Rolf M.,Lang Karl S.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23640/fullpdf

Reference43 articles.

1. Immunology of hepatitis B virus and hepatitis C virus infection;Rehermann;Nat Rev Immunol,2005

2. T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?;Zinkernagel;J Exp Med,1986

3. Extralymphatic virus sancturies as a consequence of potent T-cell activation;Recher;Nat Med,2007

4. Determinants of viral clearance and persistence during acute hepatitis C virus infection;Thimme;J Exp Med,2001

5. The role of hepatitis B virus-specific memory CD8 T cells in the control of viral replication;Sobao;J Hepatol,2002

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic and Apathogenic Strains of Lymphocytic Choriomeningitis Virus Have Distinct Entry and Innate Immune Activation Pathways;Viruses;2024-04-19

2. High-Affinity–Mediated Viral Entry Triggers Innate Affinity Escape Resulting in Type I IFN Resistance and Impaired T Cell Immunity;The Journal of Immunology;2024-03-18

3. p53 promotes antiviral innate immunity by driving hexosamine metabolism;Cell Reports;2024-02

4. A physiologically based pharmacokinetic model for V937 oncolytic virus in mice;Frontiers in Pharmacology;2023-09-13

5. Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions;Frontiers in Cellular and Infection Microbiology;2023-05-10